We are live on
!
Find out more
OQS
Occudo Quantitative Strategies Portfolio holdings
AUM
$1.84B
1-Year Est. Return
22.15%
This Fund
S&P 500
This Quarter
Est. Return
+11.71%
1 Year Est. Return
+22.15%
3 Year Est. Return
+67.4%
5 Year Est. Return
+61.87%
10 Year Est. Return
–
AUM
$457M
AUM Growth
+$138M
(+43%)
Cap. Flow
+$125M
Cap. Flow
% of AUM
27.38%
Top 10 Holdings %
Top 10 Hldgs %
5.56%
Holding
1,008
New
380
Increased
191
Reduced
147
Closed
287
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATNX
Athenex, Inc. Common Stock
ATNX
|
+$3.1M |
| 2 |
TTCF
Tattooed Chef, Inc Class A Common Stock
TTCF
|
+$2.96M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$2.77M |
| 4 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$2.76M |
| 5 |
Albemarle
ALB
|
+$2.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ingersoll Rand
IR
|
+$1.79M |
| 2 |
International Flavors & Fragrances
IFF
|
+$1.78M |
| 3 |
Baxter International
BAX
|
+$1.75M |
| 4 |
VMW
VMware, Inc
VMW
|
+$1.71M |
| 5 |
RB Global
RBA
|
+$1.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.25% |
| 2 | Industrials | 17.15% |
| 3 | Consumer Discretionary | 13.81% |
| 4 | Healthcare | 11.67% |
| 5 | Financials | 10.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Green Brick Partners
GRBK
$3.09B
| $251K | 0.05% |
11,084
+1,870
| +20% | +$39.9K |
|
552
MillerKnoll
MLKN
$1.64B
| $251K | 0.05% |
+6,097
| New | +$233K |
|
553
Fate Therapeutics
FATE
$291M
| $250K | 0.05% |
3,034
-2,731
| -47% | -$262K |
|
554
Pool Corp
POOL
$7.11B
| $250K | 0.05% |
+724
| New | +$252K |
|
555
Ring Energy
REI
$320M
| $249K | 0.05% |
+107,903
| New | +$206K |
|
556
Kulicke & Soffa
KLIC
$4.72B
| $248K | 0.05% |
5,050
-14,553
| -74% | -$631K |
|
557
Eastern Bankshares
EBC
$5.29B
| $245K | 0.05% |
+12,723
| New | +$221K |
|
558
McKesson
MCK
$96.8B
| $245K | 0.05% |
+1,255
| New | +$229K |
|
|
TGP
559
DELISTED
Teekay LNG Partners L.P.
TGP
| $245K | 0.05% |
+17,043
| New | +$230K |
|
|
TPH
560
DELISTED
Tri Pointe Homes
TPH
| $244K | 0.05% |
+12,005
| New | +$236K |
|
|
HOLX
561
DELISTED
Hologic
HOLX
| $242K | 0.05% |
3,250
+20
| +0.6% | +$1.52K |
|
562
Lumen
LUMN
$6.65B
| $242K | 0.05% |
+18,100
| New | +$225K |
|
563
Service Corp International
SCI
$11.7B
| $242K | 0.05% |
4,734
-9,464
| -67% | -$474K |
|
564
Whirlpool
WHR
$2.54B
| $242K | 0.05% |
+1,096
| New | +$218K |
|
|
VRTV
565
DELISTED
VERITIV CORPORATION
VRTV
| $241K | 0.05% |
+5,673
| New | +$163K |
|
|
EMKR
566
DELISTED
Emcore Corp
EMKR
| $241K | 0.05% |
4,412
+2,324
| +111% | +$140K |
|
567
Chemours
CC
$2.57B
| $240K | 0.05% |
+8,605
| New | +$229K |
|
568
Marriott Vacations Worldwide
VAC
$3.35B
| $240K | 0.05% |
+1,380
| New | +$215K |
|
569
PetMed Express
PETS
$42.3M
| $239K | 0.05% |
6,808
-4,033
| -37% | -$140K |
|
|
PRVB
570
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $239K | 0.05% |
22,755
-372
| -2% | -$5.24K |
|
|
NAV
571
DELISTED
Navistar International
NAV
| $239K | 0.05% |
+5,428
| New | +$239K |
|
|
572
Ingersoll Rand
IR
$34.1B
| $237K | 0.05% |
4,825
-38,626
| -89% | -$1.79M |
|
573
cbdMD
YCBD
$5.98M
| $237K | 0.05% |
+159
| New | +$231K |
|
574
Central Pacific Financial
CPF
$1.02B
| $235K | 0.05% |
+8,816
| New | +$201K |
|
575
Vail Resorts
MTN
$5.32B
| $235K | 0.05% |
+805
| New | +$234K |
|
Similar funds
RP
ABTD
KAM
FCIM
CPSAC
OFS
LOAME
DP
Occudo Quantitative Strategies's Q1 2021 Portfolio in Review
As of Q1 2021, Occudo Quantitative Strategies held 1,008 positions worth $457M, up 43% from $319M the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.
Occudo Quantitative Strategies deployed $125M of net new capital in Q1 2021, opening 380 new positions and adding to 191 existing holdings. Its largest new stake was Athenex, Inc. Common Stock: 16,167 shares worth $1.39M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Ingersoll Rand, an estimated $1.79M trimmed.
- Occudo Quantitative Strategies's largest Q1 2021 buy was Athenex, Inc. Common Stock: 16,167 shares worth $1.39M.
- Occudo Quantitative Strategies added most to Odonate Therapeutics, Inc. Common Stock in Q1 2021, an estimated $2.67M increase.
- Occudo Quantitative Strategies's biggest Q1 2021 reduction was Ingersoll Rand, cutting an estimated $1.79M.
- Occudo Quantitative Strategies fully exited International Flavors & Fragrances in Q1 2021, selling an estimated $1.78M.
- Occudo Quantitative Strategies's ten largest holdings make up 5.6% of its $457M portfolio in Q1 2021.
- Occudo Quantitative Strategies opened 380 new positions and closed 287 in Q1 2021.
- Occudo Quantitative Strategies's portfolio value rose 43% quarter-over-quarter to $457M.
Based on Occudo Quantitative Strategies's 13F filing for Q1 2021, filed 14 May 2021.